• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

Download Free Sample

Leave This Empty:

Gene Editing Technology Market, Global Outlook and Forecast 2023-2030

We has surveyed the Gene Editing Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
 

Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism.
Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments.
Gene editing relies on genetically engineered nucleases, also known as "molecular scissors," to produce site-specific double-strand breaks (DSBs) at specific locations in the genome, inducing organisms to connect via non-homologous end junctions (NHEJ) or homologous Source Recombination (HR) to repair DSB because this repair process is error-prone, resulting in targeted mutations

This report contains market size and forecasts of Gene Editing Technology in Global, including the following market information:

  • Global Gene Editing Technology Market Size 2024-2030, ($ millions)
  • The global Gene Editing Technology market is projected to reach US$ million by 2029.

Total Market by Segment:
Global Gene Editing Technology Market, by Type, 2024-2030 ($ millions)
Global Gene Editing Technology Market Segment Percentages, by Type

  • Homologous Recombination
  • Meganuclease

Global Gene Editing Technology Market, by Application, 2024-2030 ($ millions)
Global Gene Editing Technology Market Segment Percentages, by Application

  • Agriculture
  • Medical
  • Other

Global Gene Editing Technology Market, By Region and Country, 2024-2030 ($ Millions)
Global Gene Editing Technology Market Segment Percentages, by region and country

  • United States
  • Europe
  • Asia
  • China
  • Rest of World
  • Competitor Analysis

The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:

  • Thermo Fisher Scientific
  • SIGMA ALDRICH
  • Dharmacon
  • Cellectics
  • CRISPR Therapeutics
  • AstraZeneca
  • Bio Rad
  • Allele Biotech
  • Recombinetics
  • Lonza
  • GE Healthcare
  • Editas Medicine
  • Agilent Technologies
  • QIAGEN NV